TMO monthly performance report
Monthly TMO research: returns, drawdown, relative strength, seasonality, and key stats.
TMO monthly report
—
Key takeaways
- Thermo Fisher Scientific (TMO) closed August 2026 at $577.83, up 0.61% for the month and +23.89% over the trailing 12 months.
- Year-to-date, TMO is −0.28%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +8.67% versus its 200-day moving average ($531.71), a bullish technical signal.
- Over the past three years, TMO has underperformed the S&P 500 by −66.97%, with a relative strength index reading of 61.3.
- Win rate over the trailing 39 months stands at 48.7% — 19 positive months versus 20 negative months.
Thermo Fisher Scientific ended August 2026 at $577.83, posting a monthly return of +0.61%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −2.43%.
The current quarter stands at +13.59% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +8.67% versus the 200-day moving average ($531.71).
Year-to-date, TMO is −0.28% against SPY +12.89%, a gap of −13.17%. The stock is currently −10.27% below its 52-week high, with maximum 3-year drawdown at −37.48%.
| Period | TMO | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +2.32% | −0.20% | +2.52% |
| 1 Week | +0.25% | +3.90% | −3.66% |
| 1 Month | +0.61% | +3.05% | −2.43% |
| 3 Months | +20.64% | +7.11% | +13.53% |